BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 3 filers reported holding BEAM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,460 | -73.0% | 4,094 | -64.1% | 0.00% | -75.0% |
| Q2 2023 | $364,609 | +210656.6% | 11,419 | +101.7% | 0.01% | +100.0% |
| Q1 2023 | $173 | +183.6% | 5,660 | +260.5% | 0.01% | +100.0% |
| Q4 2022 | $61 | -100.0% | 1,570 | -95.4% | 0.00% | -88.9% |
| Q3 2022 | $1,642,000 | +75.4% | 34,463 | +42.5% | 0.03% | +28.6% |
| Q2 2022 | $936,000 | -28.2% | 24,182 | +6.3% | 0.02% | +75.0% |
| Q1 2022 | $1,303,000 | +506.0% | 22,749 | +745.7% | 0.01% | +200.0% |
| Q4 2021 | $215,000 | -42.8% | 2,690 | -37.7% | 0.00% | -60.0% |
| Q3 2021 | $376,000 | +32.9% | 4,316 | +96.6% | 0.01% | +42.9% |
| Q2 2021 | $283,000 | -83.6% | 2,195 | -89.8% | 0.01% | -75.9% |
| Q1 2021 | $1,726,000 | +505.6% | 21,565 | +517.9% | 0.03% | +222.2% |
| Q4 2020 | $285,000 | -35.1% | 3,490 | -80.4% | 0.01% | +80.0% |
| Q3 2020 | $439,000 | +501.4% | 17,839 | +582.4% | 0.01% | +66.7% |
| Q2 2020 | $73,000 | – | 2,614 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |